← Back to Search

Eutectic Lidocaine Prilocaine for Birth Control

Phase 4
Waitlist Available
Research Sponsored by Augusta University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English as primary language
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up procedure
Awards & highlights

Study Summary

This trial is testing whether EMLA cream is more effective than lidocaine for pain during and time to removal of Nexplanon.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You speak English as your main language.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
pain of procedure
time to perform procedure
Secondary outcome measures
How likely to recommend their anesthetic?
Provider's sense of ease of removal?

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: EMLAExperimental Treatment1 Intervention
Subjects randomized to EMLA receive one inch of EMLA cream placed at the removal site and then have an occlusive dressing placed. One hour later they have the Nexplanon device removed.
Group II: Subcutaneous LidocaineActive Control1 Intervention
Subjects randomized to subcutaneous lidocaine have 1% lidocaine injected at the removal site and then undergo Nexplanon removal.

Find a Location

Who is running the clinical trial?

Augusta UniversityLead Sponsor
210 Previous Clinical Trials
85,016 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study still accepting enrollees?

"This research endeavour has been actively looking for participants since its inception on June 1st, 2020 and is still listed as recruiting according to clinicaltrials.gov's records of the last edit which occurred on August 7th, 2020."

Answered by AI

What is the total number of participants involved in this study?

"Affirmative, the clinicaltrials.gov portal indicates that this trial is currently enrolling participants. This research project was initially published on June 1st 2020 and most recently modified on August 7th 2020; it seeks to recruit 40 people from a single site."

Answered by AI

Are there any potentially adverse effects of utilizing Eutectic Lidocaine Prilocaine?

"Because this treatment has been approved, the safety of Eutectic Lidocaine Prilocaine was rated a 3 on our team's scale."

Answered by AI

What are the primary applications for Eutectic Lidocaine Prilocaine?

"Eutectic Lidocaine Prilocaine is a commonly prescribed remedy for cervical syndrome and other medical issues such as minor burns, organ transplants, and osteoporosis."

Answered by AI

Could you provide a synopsis of prior experiments conducted with Eutectic Lidocaine Prilocaine?

"Presently, there are 120 active research studies related to Eutectic Lidocaine Prilocaine with 31 of those in Phase 3. Calgary is the hub for these trials but they are being conducted across 1096 sites around the world."

Answered by AI

Who else is applying?

How old are they?
18 - 65
What site did they apply to?
Augusta University Ob/Gyn Resident Continuity Clinic
What portion of applicants met pre-screening criteria?
Met criteria
~8 spots leftby Mar 2025